Answers are grounded in this paper and cite their sources.
High rates of negative sentinel lymph node biopsy (SLNB) in clinically node-negative (cN0) breast cancer (BC) after neoadjuvant chemotherapy (NAC) have been described. These results are associated with triple-negative (TNBC) and human epidermal growth factor receptor 2 (HER2+) subtypes achieving pathologic complete response (pCR). This study evaluates predictive variables and survival in order to assess the possible omission of SLNB after NAC.
No takes yet. Share an insight, caveat, or question.
Alors-Ruiz et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: